Upgrade to SI Premium - Free Trial

Oppenheimer Downgrades Pacira Pharmaceuticals (PCRX) to Perform

October 8, 2026 1:26 PM
Oppenheimer analyst Les Sulewski downgraded Pacira Pharmaceuticals (NASDAQ: PCRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades